36. Cash and cash equivalents
Cash and cash equivalents comprise cash, checks and balances with banks. In accordance with IAS 7 (Statement of Cash Flows) this item also includes securities with original maturities of up to three months, reflecting their high liquidity. Cash and cash equivalents as of December 31, 2009 amounted to €2,725 million (2008: €2,094 million).



Overview
Notes to the Consolidated Financial Statements of the Bayer Group
Bayer Links
Investor Relations


Advanced Search



